Barclays lowered the firm’s price target on Mondelez to $80 from $84 and keeps an Overweight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLZ:
- Mondelez Stock (NASDAQ:MDLZ): Benefiting from Emerging Markets Growth, Strong Brands
- Mondelēz International’s Near-term 2030 Targets and 2050 Net-Zero Targets Validated by Science Based Targets Initiative
- Mondelēz International to Report Q1 2024 Financial Results on April 30, 2024
- 5 Best Consumer Staples Stocks to Buy in April 2024, According to Analysts
- Mondelez International Stock (NASDAQ:MDLZ): Sweeten Your Portfolio with this S&P 500 Stock